dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorMainardes, Rubiana Mara
dc.creatorChaud, Marco Vinicius
dc.creatorGremião, Maria Palmira Daflon
dc.creatorEvangelista, Raul Cesar
dc.date2014-05-20T13:24:26Z
dc.date2016-10-25T16:45:08Z
dc.date2014-05-20T13:24:26Z
dc.date2016-10-25T16:45:08Z
dc.date2006-09-01
dc.date.accessioned2017-04-05T20:00:05Z
dc.date.available2017-04-05T20:00:05Z
dc.identifierJournal of Nanoscience and Nanotechnology. Stevenson Ranch: Amer Scientific Publishers, v. 6, n. 9-10, p. 3057-3061, 2006.
dc.identifier1533-4880
dc.identifierhttp://hdl.handle.net/11449/7569
dc.identifierhttp://acervodigital.unesp.br/handle/11449/7569
dc.identifier10.1166/jnn.2006.487
dc.identifierWOS:000240865900051
dc.identifierhttp://dx.doi.org/10.1166/jnn.2006.487
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/856178
dc.descriptionPraziquantel has been shown to be highly effective against all known species of Schistosoma infecting humans. Spherical nanoparticles made of poly(D,L-lactide-co-glycolide) acid with controlled size were designed as drug carriers. Praziquantel, a hydrophobic drug, was entrapped into the polymeric nanoparticles with 30% (w/w) of theoretical loading. The nanoparticles size was approximately of 350 nm with 66% of encapsulation efficiency. The everted gut sac model shows to be efficient to evaluate the drug permeation through the intestinal membrane. The results show that free praziquantel presents 4-fold times more permeation than praziquantel-loaded PLGA nanoparticles and physical mixture. For this drug, in special, this result can be interesting, since the nanoparticulate system can behave as a drug reservoir and/or to have a more localized effect in intestinal membrane for a prolonged period of time, since great amounts of parasites can be usually found in the mesenteric veins.
dc.languageeng
dc.publisherAmer Scientific Publishers
dc.relationJournal of Nanoscience and Nanotechnology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectnanoparticles
dc.subjectPLGA
dc.subjectpraziquantel
dc.subjectintestinal absorption
dc.titleDevelopment of praziquantel-loaded PLGA nanoparticles and evaluation of intestinal permeation by the everted gut Sac model
dc.typeOtro


Este ítem pertenece a la siguiente institución